Concepedia
1
Publications
16
Citations
H-Index
2025
Active since
Affiliations
Institut Gustave Roussy(Current)
H. Kaimakliotis is an author at Institut Gustave Roussy.
Publications per year
2025–2025
LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study
Christof Vulsteke, H. Kaimakliotis, Pongwut Danchaivijitr et al. · Annals of Oncology · 2025 · 16 citations · Full text
Rows per page
1–1 of 1